Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Treasury Shares: 2020-2025

Historic Treasury Shares for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $1.9 million.

  • Journey Medical's Treasury Shares fell 23.63% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 23.63%. This contributed to the annual value of $2.3 million for FY2024, which is 79.04% up from last year.
  • Per Journey Medical's latest filing, its Treasury Shares stood at $1.9 million for Q3 2025, which was down 19.73% from $2.4 million recorded in Q2 2025.
  • Journey Medical's Treasury Shares' 5-year high stood at $2.7 million during Q2 2024, with a 5-year trough of $708,524 in Q3 2021.
  • Over the past 3 years, Journey Medical's median Treasury Shares value was $2.0 million (recorded in 2024), while the average stood at $2.0 million.
  • In the last 5 years, Journey Medical's Treasury Shares spiked by 238.96% in 2022 and then tumbled by 43.13% in 2023.
  • Quarterly analysis of 5 years shows Journey Medical's Treasury Shares stood at $715,030 in 2021, then spiked by 216.22% to $2.3 million in 2022, then crashed by 42.20% to $1.3 million in 2023, then soared by 79.04% to $2.3 million in 2024, then dropped by 23.63% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $2.4 million for Q2 2025, and $2.3 million during Q1 2025.